Your browser doesn't support javascript.
loading
Real-world practice-based prognostic model for higher-risk myelodysplastic syndromes treated with azacitidine monotherapy: The Kyoto prognostic scoring system.
Okamoto, Haruya; Inoue, Yu; Miyashita, Akihiro; Kawaji-Kanayama, Yuka; Chinen, Shotaro; Fujino, Takahiro; Tsukamoto, Taku; Shimura, Yuji; Mizutani, Shinsuke; Kaneko, Hiroto; Kuwahara-Ota, Saeko; Fuchida, Shin-Ichi; Nishiyama, Daichi; Hirakawa, Koichi; Uchiyama, Hitoji; Uoshima, Nobuhiko; Kawata, Eri; Kuroda, Junya.
Afiliação
  • Okamoto H; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan.
  • Inoue Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan.
  • Miyashita A; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan.
  • Kawaji-Kanayama Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan.
  • Chinen S; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan.
  • Fujino T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan.
  • Tsukamoto T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan.
  • Shimura Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan.
  • Mizutani S; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan.
  • Kaneko H; Division of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan.
  • Kuwahara-Ota S; Division of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
  • Fuchida SI; Division of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
  • Nishiyama D; Division of Hematology, Fukuchiyama City Hospital, Kyoto, Japan.
  • Hirakawa K; Division of Hematology, Fukuchiyama City Hospital, Kyoto, Japan.
  • Uchiyama H; Division of Hematology, Japanese Red Cross Society Kyoto Daiichi Hospital, Kyoto, Japan.
  • Uoshima N; Division of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Kawata E; Division of Hematology, Matsushita Memorial Hospital, Moriguchi, Japan.
  • Kuroda J; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan. junkuro@koto.kpu-m.ac.jp.
Int J Hematol ; 118(3): 323-332, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37378717
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article